Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 3 (2006), Issue 9 (September)

1. Cognitive impairment in bipolar II disorder.
   Br J Psychiatry, 189: 254-9. [Abstract] [Full-text]
2. Modelling facets of mania--new directions related to the notion of endophenotypes.
   J Psychopharmacol, 20(5): 714-22. [Abstract] [Full-text]
3. The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder.
   J Psychopharmacol, 20(5): 602-10. [Abstract] [Full-text]
4. Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease.
   J Physiol, 575: 411-6. [Abstract] [Full-text]
5. Further evidence for a developmental subtype of bipolar disorder defined by age at onset: results from the national epidemiologic survey on alcohol and related conditions.
   Am J Psychiatry, 163(9): 1633-6. [Abstract] [Full-text]
6. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers.
   Am J Psychiatry, 163(9): 1561-8. [Abstract] [Full-text]
7. Familiality of postpartum depression in unipolar disorder: results of a family study.
   Am J Psychiatry, 163(9): 1549-53. [Abstract] [Full-text]
8. Does this patient really want treatment? Factors associated with baseline and evolving readiness for change among hospitalized substance using adults interested in treatment.
   Addict Behav, 31(10): 1904-18. [Abstract] [Full-text]
9. Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder.
   Epilepsy Behav, 9(2): 327-34. [Abstract] [Full-text]
10. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.
    Hum Mol Genet, 15(18): 2804-12. [Abstract] [Full-text]
11. Lithium alters regional rat brain myo-inositol at 2 and 4 weeks: an ex-vivo magnetic resonance spectroscopy study at 18.8 T.
    Neuroreport, 17(12): 1323-6. [Abstract] [Full-text]
12. Serotonin 1a receptor and associated G-protein activation in schizophrenia and bipolar disorder.
    Psychiatry Res, 143(2): 111-20. [Abstract] [Full-text]
13. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
    Schizophr Bull, 32(4): 644-54. [Abstract] [Full-text]
14. An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients.
    Clin Pract Epidemol Ment Health, 2: 19. [Abstract] [Full-text]
15. Topiramate raises anterior cingulate cortex glutamine levels in healthy men; a 4.0 T magnetic resonance spectroscopy study.
    Psychopharmacology (Berl), 188(2): 236-43. [Abstract] [Full-text]
16. Ethnic comparisons of the 12 month prevalence of mental disorders and treatment contact in Te Rau Hinengaro: the New Zealand Mental Health Survey.
    Aust N Z J Psychiatry, 40(10): 905-13. [Abstract] [Full-text]
17. Prevalence, interference with life and severity of 12 month DSM-IV disorders in Te Rau Hinengaro: the New Zealand Mental Health Survey.
    Aust N Z J Psychiatry, 40(10): 845-54. [Abstract] [Full-text]
18. Clinical features of soft bipolarity in major depressive inpatients.
    Psychiatry Clin Neurosci, 60(5): 611-5. [Abstract] [Full-text]
19. The neuroprotective agent, valproic acid, regulates the mitogen-activated protein kinase pathway through modulation of protein kinase A signalling in Dictyostelium discoideum.
    Eur J Cell Biol, 85(9): 1047-57. [Abstract] [Full-text]
20. Evidence that the urban environment specifically impacts on the psychotic but not the affective dimension of bipolar disorder.
    Soc Psychiatry Psychiatr Epidemiol, 41(9): 679-85. [Abstract] [Full-text]
21. First psychiatric hospitalizations in the US military: the National Collaborative Study of Early Psychosis and Suicide (NCSEPS).
    Psychol Med, 36(10): 1405-15. [Abstract] [Full-text]
22. Managing aggression in a psychiatric hospital using a behaviour plan: a case study.
    J Psychiatr Ment Health Nurs, 13(5): 515-21. [Abstract] [Full-text]
23. Mania and intellectual disability: the course of manic symptoms in persons with intellectual disability.
    Am J Ment Retard, 111(5): 378-83. [Abstract] [Full-text]
24. No allelic association or interaction of three known functional polymorphisms with bipolar disorder in a northern Swedish isolated population.
    Psychiatr Genet, 16(5): 209-12. [Abstract] [Full-text]
25. No association between genetic variants at the GRIN1 gene and bipolar disorder in a German sample.
    Psychiatr Genet, 16(5): 183-4. [Abstract] [Full-text]
26. Catechol-O-methyltransferase gene variants in mood disorders in the Italian population.
    Psychiatr Genet, 16(5): 181-2. [Abstract] [Full-text]
27. Measuring health-related quality of life in bipolar disorder: Relationship of the EuroQol (EQ-5D) to condition-specific measures.
    Qual Life Res. [Abstract] [Full-text]
28. Premorbid Adjustment in Bipolar Disorder: Comparison With Schizophrenia.
    J Nerv Ment Dis, 194(9): 654-658. [Abstract] [Full-text]
29. Naturalistic long-term use of methylphenidate in bipolar disorder.
    J Clin Psychopharmacol, 26(5): 516-8. [Abstract] [Full-text]
30. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    J Clin Psychopharmacol, 26(5): 467-73. [Abstract] [Full-text]
31. The child bipolar questionnaire: a dimensional approach to screening for pediatric bipolar disorder.
    J Affect Disord, 95(1): 149-58. [Abstract] [Full-text]
32. Long-term outcome of antidepressant-refractory depression: the relevance of unrecognized bipolarity.
    J Affect Disord, 95(1): 61-7. [Abstract] [Full-text]
33. Cannabis use and expression of mania in the general population.
    J Affect Disord, 95(1): 103-10. [Abstract] [Full-text]
34. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    J Affect Disord, 95(1): 69-78. [Abstract] [Full-text]
35. Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia.
    J Affect Disord, 95(1): 13-7. [Abstract] [Full-text]
36. An increased proportional representation of bipolar disorder in younger depressed patients: analysis of two clinical databases.
    J Affect Disord, 95(1): 141-4. [Abstract] [Full-text]
37. The stress sensitization hypothesis: understanding the course of bipolar disorder.
    J Affect Disord, 95(1): 43-9. [Abstract] [Full-text]
38. Assessing side effects of pharmacotherapy treatment of bipolar disorder: A 20-year review of the literature.
    Res Dev Disabil, 27(5): 467-500. [Abstract] [Full-text]
39. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder.
    Neurosci Lett, 407(2): 146-50. [Abstract] [Full-text]
40. Screening for serious mental illness in populations with co-occurring substance use disorders: Performance of the K6 scale.
    J Subst Abuse Treat, 31(3): 287-96. [Abstract] [Full-text]
41. Effects of olanzapine on aggressiveness in heroin dependent patients.
    Prog Neuropsychopharmacol Biol Psychiatry, 30(7): 1291-8. [Abstract] [Full-text]
42. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes.
    Mol Psychiatry, 11(10): 965-78. [Abstract] [Full-text]
43. A comparative study of consumer participation in mental health pharmacy education.
    Ann Pharmacother, 40(10): 1759-65. [Abstract] [Full-text]
44. Comparison of clinical characteristics in episodic and chronic obsessive-compulsive disorder.
    Depress Anxiety. [Abstract] [Full-text]
45. Classification of adolescent psychotic disorders using linear discriminant analysis.
    Schizophr Res, 87(1): 297-306. [Abstract] [Full-text]
46. Impaired hemispheric communication in schizophrenia: a study using the consonant-vowel-consonant task.
    Schizophr Res, 87(1): 279-88. [Abstract] [Full-text]
47. Global visual scanning abnormalities in schizophrenia and bipolar disorder.
    Schizophr Res, 87(1): 212-22. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.